Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 3, 2009, Pages 294-301

  Belhassen, Bernard ^a   Glick, Aharon ^b   Viskin, Sami ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brugada syndrome; Electrophysiologic study; Idiopathic ventricular fibrillation; Programmed ventricular stimulation; Quinidine

Indexed keywords

DIHYDROQUINIDINE; QUINIDINE ACID SULFATE;

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IDIOPATHIC DISEASE; MALE; POLYMORPHIC VENTRICULAR TACHYCARDIA; PROPHYLAXIS; RECURRENT DISEASE; REPRODUCIBILITY; SYNCOPE;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; CLINICAL TRIALS AS TOPIC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUINIDINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; YOUNG ADULT;

EID: 61449172124     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02235.x     Document Type: Article

References (24)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006 48 : e247 e346.
2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, et al. Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 111 : 659 670.
3. Marquez MF, Salica G, Hermosillo AG, Pastelin G, Gomes-Flores J, Nava S. Ionic basis of pharmacological therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2007 18 : 234 240.
4. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita D. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007 4 : 695 700.
5. Belhassen B, Shapira I, Shoshani D, Paredes A, Miller H, Laniado S. Idiopathic ventricular fibrillation: Inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 1987 75 : 809 816.
6. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on long-term outcome in patients with idiopathic ventricular fibrillation and the Brugada syndrome. J Cardiovasc Electrophysiol 1999 10 : 1301 1312.
7. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004 110 : 1731 1737.
8. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: Is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol 2002 25 : 1634 1640.
9. Belhassen B, Pelleg A, Miller HI, Laniado S. Serial electrophysiological studies in a young patient with recurrent ventricular fibrillation. Pacing Clin Electrophysiol 1981 4 : 92 99.
10. Belhassen B. A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy. Heart Rhythm 2004 1 : 352 354.
11. Belhassen B, Shapira I, Sheps D, Shoshani D, Laniado S. Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: A new highly sensitive and specific protocol. Am J Cardiol 1990 65 : 615 622.
12. Viskin S, Antzelevitch C, Marquez MF, Belhassen B. Quinidine: A valuable medication joins the list of "endangered species." Europace 2007 9 : 1105 1106.
13. Dock W. Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulfate. Am Heart J 1929 4 : 709 714.
14. Moe T. Morgagni-Adams-Stokes attacks caused by transient recurrent ventricular fibrillation in a patient without apparent heart disease. Am Heart J 1949 37 : 811 818.
15. Konty F, Dale J. Self-terminating idiopathic ventricular fibrillation presenting as syncope: A 40-year follow-up report. J Intern Med 1990 227 : 211 213.
16. Aizawa Y, Naitoh N, Washizuka T, Takahashi K, Uchiyama H, Shiba M, Shibata A. Electrophysiological findings in idiopathic recurrent ventricular fibrillation: Special reference to mode of induction, drug testing and long-term outcomes. Pacing Clin Electrophysiol 1996 19 : 929 939.
17. Wever EFD, Hauer RNW, Oomen A, Peters RHJ, Bakker PFA, Robles de Medina EO. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993 88 : 1021 1029.
18. Otto C, Tauxe R, Cobb L, Greene HL, Gross BW, Werner JA, Burroughs RW, et al. Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med 1984 100 : 45 47.
19. Garg A, Finneran W, Feld GK. Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998 9 : 642 647.
20. Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004 43 : 1853 1860.
21. Mizusawa Y, Sakurada H, Nishizaki M, Hiraoka M. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: Low-dose quinidine therapy as an adjunctive treatment. J Cardiovasc Pharmacol 2006 47 : 359 364.
22. Paul M, Gerss J, Schultze-Bahr E, Wichter T, Vahlhaus C, Wilde AA, Breithardt G, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: A meta-analysis of worldwide published data. Eur Heart J 2007 28 : 2126 2133.
23. Viskin S, Rogowski O. Asymptomatic Brugada syndrome: A cardiac ticking time-bomb? Europace 2007 9 : 707 710.
24. Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, et al. Outcome after implantation of cardioverter defibrillator in patients with Brugada syndrome: A multicenter Israeli study (ISRABRU). IMAJ 2008 10 : 435 439.